The Catecholamine Release-Inhibitory “Catestatin” Fragment of Chromogranin A: Naturally Occurring Human Variants with Different Potencies for Multiple Chromaffin Cell Nicotinic Cholinergic Responses

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Molecular Pharmacology

• Publication date

  2004-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1124/MOL.104.002139PMID 15326220
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Both rare and common polymorphisms contribute functional variation at CHGA, a regulator of catecholamine physiology.

  2004cited by this paper
• Conformational preferences and activities of peptides from the catecholamine release-inhibitory (catestatin) region of chromogranin A.

  2004cited by this paper
• Animal models of pheochromocytoma.

  2004cited by this paper
• Catecholamine Secretory Vesicle Stimulus-Transcription Coupling in Vivo

  2003cited by this paper
• Secretin Activation of Chromogranin A Gene Transcription

  2003cited by this paper
• Primary sequence characterization of catestatin intermediates and peptides defines proteolytic cleavage sites utilized for converting chromogranin a into active catestatin secreted from neuroendocrine chromaffin cells.

  2003cited by this paper
• Antidepressant-like effect of agmatine and its possible mechanism.

  2003cited by this paper
• Modulatory Mechanism of the Endogenous Peptide Catestatin on Neuronal Nicotinic Acetylcholine Receptors and Exocytosis

  2002cited by this paper
• The sympathetic nervous system: the muse of primary hypertension

  2002cited by this paper
• Chromaffin cell catecholamine secretion: bisindolylmaleimide compounds exhibit novel and potent antagonist effects at the nicotinic cholinergic receptor in pheochromocytoma cells.

  2002cited by this paper
• Early decline in the catecholamine release-inhibitory peptide catestatin in humans at genetic risk of hypertension.

  2002cited by this paper
• Formation of the Catecholamine Release-inhibitory Peptide Catestatin from Chromogranin A

  2000cited by this paper
• The ‘adrenaline hypothesis’ of hypertension revisited: evidence for adrenaline release from the heart of patients with essential hypertension

  2000cited by this paper
• Primary structure and function of the catecholamine release inhibitory peptide catestatin (chromogranin A(344-364)): identification of amino acid residues crucial for activity.

  2000cited by this paper
• THE NOVEL CATECHOLAMINE RELEASE-INHIBITORY PEPTIDE CATESTATIN (CHROMOGRANIN A344 -364) ACTS AT THE RECEPTOR TO PREVENT NICOTINIC CHOLINERGIC TOLERANCE*

  1999cited by this paper
• Catecholamine storage vesicle protein expression in genetic hypertension.

  1999cited by this paper
• Desensitization of Catecholamine Release

  1999cited by this paper
• Time-dependent effects of the neuropeptide PACAP on catecholamine secretion : stimulation and desensitization.

  1999cited by this paper
• Peptidergic activation of transcription and secretion in chromaffin cells. Cis and trans signaling determinants of pituitary adenylyl cyclase-activating polypeptide (PACAP).

  1998cited by this paper
• Mechanism of action of chromogranin A on catecholamine release: molecular modeling of the catestatin region reveals a beta-strand/loop/beta-strand structure secured by hydrophobic interactions and predictive of activity.

  1998cited by this paper
• Unmasking the functions of the chromaffin cell alpha7 nicotinic receptor by using short pulses of acetylcholine and selective blockers.

  1998influential reference
• A crucial role for the mitogen-activated protein kinase pathway in nicotinic cholinergic signaling to secretory protein transcription in pheochromocytoma cells.

  1998cited by this paper
• Stimulus coupling to transcription versus secretion in pheochromocytoma cells. Convergent and divergent signal transduction pathways and the crucial roles for route of cytosolic calcium entry and protein kinase C.

  1997cited by this paper
• Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist.

  1997cited by this paper
• Stimulus-transcription Coupling in Pheochromocytoma Cells

  1996cited by this paper
• Vesicular monoamine transport inhibitors. Novel action at calcium channels to prevent catecholamine secretion.

  1996cited by this paper
• Chromogranin A in human hypertension. Influence of heredity.

  1995cited by this paper
• 1995 Receptor and ion channel nomenclature supplement.

  1995cited by this paper
• Epibatidine, a potent analgetic and nicotinic agonist.

  1994cited by this paper
• Catecholamine secretory vesicles. Augmented chromogranins and amines in secondary hypertension.

  1993cited by this paper
• Vasostatins, Comprising the N‐terminal Domain of Chromogranin A, Suppress Tension in Isolated Human Blood Vessel Segments

  1993cited by this paper
• The chromogranins A and B: The first 25 years and future perspectives

  1992cited by this paper
• Structure and function of the chromogranin A gene. Clues to evolution and tissue-specific expression.

  1991cited by this paper
• Identification of a brain acetylcholine receptor alpha subunit able to bind alpha-bungarotoxin.

  1990cited by this paper
• Is physiologic sympathoadrenal catecholamine release exocytotic in humans?

  1990cited by this paper
• An Increased Pool of Secretory Hormones and Peptides in Adrenal Medulla of Stroke‐Prone Spontaneously Hypertensive Rats

  1989cited by this paper
• Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion

  1986cited by this paper
• Human chromogranin A. Purification and characterization from catecholamine storage vesicles of human pheochromocytoma.

  1984cited by this paper
• Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor.

  1976cited by this paper
• Adrenal chromaffin granules: isolation and disassembly.

  1974cited by this paper
• [39] Adrenal chromaffin granules: Isolation and disassembly

  1974cited by this paper
• Introduction to Quantitative Genetics.

  1962cited by this paper

• The physiological anti-hypertensive peptide catestatin and its common human variant Gly364Ser: differential cardiovascular effects in a rat model of hypertension

  2024cites this paper
• Prognostic Value of Plasma Catestatin Concentration in Patients with Heart Failure with Reduced Ejection Fraction in Two-Year Follow-Up

  2023cites this paper
• Serum Catestatin Levels Correlate with Ambulatory Blood Pressure and Indices of Arterial Stiffness in Patients with Primary Hypertension

  2022cites this paper
• Role of Catestatin in the Cardiovascular System and Metabolic Disorders

  2022cites this paper
• Catestatin as a Biomarker of Cardiovascular Diseases: A Clinical Perspective

  2021cites this paper
• A systematic review of chromogranin A (CgA) and its biomedical applications, unveiling its structure-related functions

  2020cites this paper
• Catestatin as a New Prognostic Marker in Stable Patients with Heart Failure with Reduced Ejection Fraction in Two-Year Follow-Up

  2020cites this paper
• Chromogranin A and its fragments in cardiovascular, immunometabolic, and cancer regulation

  2019cites this paper
• Chromogranin A: From Laboratory to Clinical Aspects of Patients with Neuroendocrine Tumors

  2018cites this paper
• Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame.

  2018cites this paper
• D-Cateslytin: a new antifungal agent for the treatment of oral Candida albicans associated infections

  2018cites this paper
• Catestatin regulates vesicular quanta through modulation of cholinergic and peptidergic (PACAPergic) stimulation in PC12 cells

  2018cites this paper
• Chromogranins: from Cell Biology to Physiology and Biomedicine

  2017cites this paper
• Biological Roles of the Eclectic Chromogranin-A-derived Peptide Catestatin.

  2017cites this paper
• Granin-derived peptides.

  2017influential citation
• Chromogranin A Regulation of Obesity and Peripheral Insulin Sensitivity

  2017cites this paper
• . Cell Cellular Lif Sci J 2017, 2(2): 000115

  2017cites this paper
• Comparative Aspects of CgA-Derived Peptides in Cardiac Homeostasis

  2017cites this paper
• Acetylcholine nicotinic receptor subtypes in chromaffin cells

  2017cites this paper
• Naturally Occurring Single Nucleotide Polymorphisms in Human Chromogranin A (CHGA) Gene: Association with Hypertension and Associated Diseases

  2017cites this paper
• Catestatin and vasostatin concentrations in healthy dogs

  2017cites this paper
• Catestatin, vasostatin, cortisol, and pain assessments in dogs suffering from traumatic bone fractures

  2017influential citation
• Chromogranin A-Derived Peptides in Cardiac Pre- and Post-conditioning

  2017cites this paper
• Chromogranin A Epitopes Catestatin and Vasostatin Evaluation of their Potential Use as Clinical Biomarkers for Psychological and Pain-induced Stress in Dogs

  2017influential citation
• Analysis and validation of traits associated with a single nucleotide polymorphism Gly364Ser in catestatin using humanized chromogranin A mouse models

  2016cites this paper
• Chronic Administration of Catestatin Improves Autonomic Function and Exerts Cardioprotective Effects in Myocardial Infarction Rats

  2016cites this paper
• Catestatin Gly364Ser Variant Alters Systemic Blood Pressure and the Risk for Hypertension in Human Populations via Endothelial Nitric Oxide Pathway

  2016cites this paper
• Catestatin, vasostatin, cortisol, temperature, heart rate, respiratory rate, scores of the short form of the Glasgow composite measure pain scale and visual analog scale for stress and pain behavior in dogs before and after ovariohysterectomy

  2016influential citation
• Catestatin Gly 364 Ser Variant Alters Systemic Blood Pressure and the Risk for Hypertension in Human Populations via Endothelial Nitric Oxide Pathway

  2016cites this paper
• Potential applications of catestatin in cardiovascular diseases.

  2016cites this paper
• A common genetic variant of the chromogranin A-derived peptide catestatin is associated with atherogenesis and hypertension in a Japanese population.

  2015cites this paper
• Catestatin attenuates endoplasmic reticulum induced cell apoptosis by activation type 2 muscarinic acetylcholine receptor in cardiac ischemia/reperfusion

  2015cites this paper
• Regulation of intestinal SGLT1 by catestatin in hyperleptinemic type 2 diabetic mice

  2015cites this paper
• verificationpathway identification, and experimental A-null model of hypertension: transcriptomic Global metabolic consequences of the chromogranin

  2015cites this paper
• Predictive markers and risk factors in canine pyometra

  2015cites this paper
• Pyroglutamate-Amyloid-β and Glutaminyl Cyclase Are Colocalized with Amyloid-β in Secretory Vesicles and Undergo Activity-Dependent, Regulated Secretion

  2014cites this paper
• Cardio-vascular activity of catestatin: interlocking the puzzle pieces.

  2014cites this paper
• The important role of catestatin in cardiac remodeling

  2014influential citation
• The relationship of plasma catestatin concentrations with metabolic and vascular parameters in untreated hypertensive patients: Influence on high-density lipoprotein cholesterol

  2014cites this paper
• Beta-amyloid peptides undergo regulated co-secretion with neuropeptide and catecholamine neurotransmitters.

  2013cites this paper
• Development of a pharmacophore model for the catecholamine release-inhibitory peptide catestatin: virtual screening and functional testing identify novel small molecule therapeutics of hypertension.

  2013cites this paper
• MicroRNA-22 and promoter motif polymorphisms at the Chga locus in genetic hypertension: functional and therapeutic implications for gene expression and the pathogenesis of hypertension.

  2013cites this paper
• Cardioprotection against ischemia/reperfusion injury and chromogranin A-derived peptides.

  2012cites this paper
• Catestatin, a chromogranin A-derived peptide, is sympathoinhibitory and attenuates sympathetic barosensitivity and the chemoreflex in rat CVLM.

  2012cites this paper
• Molecular interactions of the physiological anti-hypertensive peptide catestatin with the neuronal nicotinic acetylcholine receptor

  2012influential citation
• Functional Genetic Variants of the Catecholamine-Release-Inhibitory Peptide Catestatin in an Indian Population

  2012cites this paper
• Catestatin (Chromogranin A352–372) and Novel Effects on Mobilization of Fat from Adipose Tissue through Regulation of Adrenergic and Leptin Signaling*

  2012cites this paper
• Enrichment of the inositol 1,4,5-trisphosphate receptor/Ca2+ channels in secretory granules and essential roles of chromogranins.

  2012cites this paper
• Brain excitatory/inhibitory circuits cross-talking with chromogranin A during hypertensive and hibernating states.

  2012cites this paper
• Human catestatin enhances migration and proliferation of normal human epidermal keratinocytes.

  2011cites this paper
• Chromogranin peptides in brain diseases

  2011cites this paper
• Catestatin, a neuroendocrine antimicrobial peptide, induces human mast cell migration, degranulation and production of cytokines and chemokines

  2011cites this paper
• A novel catestatin-induced antiadrenergic mechanism triggered by the endothelial PI3K-eNOS pathway in the myocardium.

  2011cites this paper
• The extended granin family: structure, function, and biomedical implications.

  2011cites this paper
• Global metabolic consequences of the chromogranin A-null model of hypertension: transcriptomic detection, pathway identification, and experimental verification.

  2010cites this paper
• Chromogranin a and the autonomic system: decomposition of heart rate variability and rescue by its catestatin fragment.

  2010cites this paper
• Human catestatin peptides differentially regulate infarct size in the ischemic-reperfused rat heart.

  2010cites this paper
• Catestatin: a multifunctional peptide from chromogranin A.

  2010cites this paper
• The catecholamine release-inhibitory peptide catestatin (chromogranin A344-364) modulates myocardial function in fish

  2010influential citation
• Secretory granules in inositol 1,4,5‐trisphosphate‐dependent Ca2+ signaling in the cytoplasm of neuroendocrine cells

  2010cites this paper
• The mechanism of the development of hepatic insulin sensitivity in chromogranin a null mice

  2010cites this paper
• Secretoneurin is a Neuropeptide Regulating Luteinizing Hormone Release from Pituitary Gonadotrophs

  2010cites this paper
• Catecholamines, cardiac natriuretic peptides and chromogranin A: evolution and physiopathology of a ‘whip-brake’ system of the endocrine heart

  2010influential citation
• Catestatin Improves Post-Ischemic Left Ventricular Function and Decreases Ischemia/Reperfusion Injury in Heart

  2010cites this paper
• Catestatin in rat RVLM is sympathoexcitatory, increases barosensitivity, and attenuates chemosensitivity and the somatosympathetic reflex.

  2010cites this paper
• Reprint of: Catestatin: A multifunctional peptide from chromogranin A

  2010cites this paper
• Chromogranin peptides in amyotrophic lateral sclerosis.

  2009cites this paper
• The Endocrine–Paracrine Control of the Cardiovascular System

  2009cites this paper
• Global disturbances in autonomic function yield cardiovascular instability and hypertension in the chromogranin a null mouse.

  2009cites this paper
• Cathepsin L colocalizes with chromogranin a in chromaffin vesicles to generate active peptides.

  2009cites this paper
• Levels of Salivary Chromogranin-A Secreted During Simulated Monotonous Driving Stress

  2009cites this paper
• New insights into granin-derived peptides: evolution and endocrine roles.

  2009cites this paper
• Relationship between salivary Chromogranin-A and stress induced by simulated monotonous driving

  2009cites this paper
• Cromogranina A. La familia cromogranina-secretogranina

  2008cites this paper
• Proteolytic cleavage of human chromogranin a containing naturally occurring catestatin variants: differential processing at catestatin region by plasmin.

  2008cites this paper
• The antihypertensive chromogranin a peptide catestatin acts as a novel endocrine/paracrine modulator of cardiac inotropism and lusitropism.

  2008cites this paper
• Heritability and Genome-Wide Linkage in US and Australian Twins Identify Novel Genomic Regions Controlling Chromogranin A: Implications for Secretion and Blood Pressure

  2008cites this paper
• Catestatin is a novel endogenous peptide that regulates cardiac function and blood pressure.

  2008cites this paper
• Catestatin (chromogranin A344-364) is a novel cardiosuppressive agent: inhibition of isoproterenol and endothelin signaling in the frog heart.

  2008cites this paper
• Hereditary Determinants of Human Hypertension: Strategies in the Setting of Genetic Complexity

  2008cites this paper
• The neuroendocrine peptide catestatin is a cutaneous antimicrobial and induced in the skin after injury.

  2008cites this paper
• Monocyte migration: a novel effect and signaling pathways of catestatin.

  2008cites this paper
• Biogenesis of the secretory granule: chromogranin A coiled-coil structure results in unusual physical properties and suggests a mechanism for granule core condensation.

  2007cites this paper
• Physiologie de la médullosurrénale

  2007cites this paper
• Chapter 72 – Catecholamines, Pheochromocytoma, and Hypertension: Genomic Insights

  2007cites this paper
• Chromogranins A and B and secretogranin II: evolutionary and functional aspects

  2007cites this paper
• Renal Albumin Excretion: Twin Studies Identify Influences of Heredity, Environment, and Adrenergic Pathway Polymorphism

  2007cites this paper
• The chromogranin A fragment catestatin: specificity, potency and mechanism to inhibit exocytotic secretion of multiple catecholamine storage vesicle co-transmitters

  2006cites this paper
• Quantification of VGF- and pro-SAAS-derived peptides in endocrine tissues and the brain, and their regulation by diet and cold stress.

  2006cites this paper
• Catecholamine storage vesicles and the metabolic syndrome: the role of the chromogranin A fragment pancreastatin

  2006cites this paper
• Targeted ablation of the chromogranin a (Chga) gene: normal neuroendocrine dense-core secretory granules and increased expression of other granins.

  2006cites this paper
• Pleiotropic effects of novel trans-acting loci influencing human sympathochromaffin secretion.

  2006cites this paper
• Familial orthostatic tachycardia

  2006cites this paper
• New antimicrobial activity for the catecholamine release-inhibitory peptide from chromogranin A

  2005cites this paper
• Hypertension from targeted ablation of chromogranin A can be rescued by the human ortholog.

  2005cites this paper
• Online Supplement : Novel peptide isomer strategy for stable inhibition of catecholamine release : Application to hypertension

  year unknowncites this paper
• Catestatin (chromogranin a 344-364 ) Is a Novel Cardiosuppressive Agent: Inhibition of Isoproterenol and Endothelin Signaling in the Frog Heart Running Head: Catestatin Modulation of Myocardial Activity

  year unknowncites this paper